# Thiamine Supplementation in Patients With Septic Shock

> **NCT03122678** · PHASE1 · WITHDRAWN · sponsor: **The Cleveland Clinic**

## Conditions studied

- Septic Shock
- Shock, Septic
- Lactic Acidosis
- Thiamine Deficiency

## Interventions

- **DRUG:** Thiamine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03122678
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11-05
- **Primary completion:** 2019-03-14
- **Final completion:** 2019-03-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participant enrolled
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122678, "Thiamine Supplementation in Patients With Septic Shock". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03122678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*